{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:12:12Z","timestamp":1769598732490,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.mehy.2020.110342","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T12:39:03Z","timestamp":1602160743000},"page":"110342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"145","author":[{"given":"Sara","family":"Morsy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110342_b0005","doi-asserted-by":"crossref","unstructured":"Sedaghat Z, Karimi N, Guillain Barre syndrome associated with COVID-19 infection: a case report, J Clin Neurosci (2020), pp. S0967-5868(0920)30882-30881.","DOI":"10.1016\/j.jocn.2020.04.062"},{"issue":"26","key":"10.1016\/j.mehy.2020.110342_b0010","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain\u2013Barr\u00e9 Syndrome Associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.110342_b0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.mehy.2020.110342_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2020.e00771","article-title":"Guillain-Barr\u00e9 Syndrome associated with SARS-CoV-2 infection","volume":"20","author":"Virani","year":"2020","journal-title":"IDCases"},{"key":"10.1016\/j.mehy.2020.110342_b0025","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 Syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.110342_b0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.mehy.2020.110342_b0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.mehy.2020.110342_b0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3988\/jcn.2017.13.3.227","article-title":"Neurological complications during treatment of middle east respiratory syndrome","volume":"13","author":"Kim","year":"2017","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.mehy.2020.110342_b0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","volume":"87","author":"Wu","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.mehy.2020.110342_b0050","series-title":"Structure and function of the neural cell adhesion molecule NCAM","first-page":"213","article-title":"Biosynthesis of NCAM","author":"Kolkova","year":"2010"},{"key":"10.1016\/j.mehy.2020.110342_b0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1365-2990.1999.00178.x","article-title":"NCAM, vimentin and neonatal myosin heavy chain expression in human muscle diseases","volume":"25","author":"Winter","year":"1999","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.mehy.2020.110342_b0060","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/CCM.0000000000002208","article-title":"Muscle weakness and 5-year survival in acute respiratory distress syndrome survivors","volume":"45","author":"Dinglas","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.mehy.2020.110342_b0065","first-page":"419","article-title":"Respiratory muscle fatigue: a cause of respiratory failure?","volume":"53","author":"Macklem","year":"1977","journal-title":"Clin Sci Mol Med"},{"key":"10.1016\/j.mehy.2020.110342_b0070","doi-asserted-by":"crossref","first-page":"D482","DOI":"10.1093\/nar\/gkw1065","article-title":"Virus Variation Resource \u2013 improved response to emergent viral outbreaks","volume":"45","author":"Hatcher","year":"2017","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.mehy.2020.110342_b0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barre syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J Peripheral Nervous System: JPNS"},{"key":"10.1016\/j.mehy.2020.110342_b0080","doi-asserted-by":"crossref","DOI":"10.1097\/WCO.0000000000000233","article-title":"Paranodal and other autoantibodies in chronic inflammatory neuropathies","volume":"28","author":"Querol","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.mehy.2020.110342_b0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.0000000000000566","article-title":"Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barre syndrome","volume":"83","author":"Sawai","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2020.110342_b0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrneurol.2014.260","article-title":"Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders","volume":"11","author":"Stathopoulos","year":"2015","journal-title":"Nature Rev Neurol"},{"key":"10.1016\/j.mehy.2020.110342_b0095","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00415-008-0815-9","article-title":"Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barre syndrome","volume":"255","author":"Wanschitz","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.mehy.2020.110342_b0100","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.autrev.2016.03.020","article-title":"Zika virus and autoimmunity: from microcephaly to Guillain-Barr\u00e9 syndrome, and beyond","volume":"15","author":"Lucchese","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.mehy.2020.110342_b0105","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"The UniProt","year":"2018","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.mehy.2020.110342_b0110","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1111\/j.1742-4658.2005.04945.x","article-title":"Protein database searches using compositionally adjusted substitution matrices","volume":"272","author":"Altschul","year":"2005","journal-title":"FEBS J"},{"issue":"2019","key":"10.1016\/j.mehy.2020.110342_b0115","first-page":"D339","article-title":"The Immune Epitope Database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2018","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.mehy.2020.110342_b0120","doi-asserted-by":"crossref","first-page":"W431","DOI":"10.1093\/nar\/gkv495","article-title":"GalaxyPepDock: a protein\u2013peptide docking tool based on interaction similarity and energy optimization","volume":"43","author":"Lee","year":"2015","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.mehy.2020.110342_b0125","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.mehy.2020.110342_b0130","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.mehy.2020.110342_b0135","series-title":"Neurobiology of brain disorders","first-page":"167","article-title":"Chapter 12 \u2013 Peripheral neuropathies","author":"Saporta","year":"2015"},{"key":"10.1016\/j.mehy.2020.110342_b0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jns.2018.10.023","article-title":"Plasma levels of soluble NCAM in multiple sclerosis","volume":"396","author":"Ziliotto","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.mehy.2020.110342_b0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0304-3940(86)90304-6","article-title":"Reactivity with neural cell adhesion molecules in sera from patients with demyelinating diseases","volume":"65","author":"Poltorak","year":"1986","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2020.110342_b0150","doi-asserted-by":"crossref","unstructured":"Leshchyns'ka I, Liew HT, Shepherd C, et al., A\u03b2-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease, Nat Commun 6 (2015), pp. 8836-8836.","DOI":"10.1038\/ncomms9836"},{"key":"10.1016\/j.mehy.2020.110342_b0155","first-page":"417","article-title":"Expression of the neural cell adhesion molecule and polysialic acid in human neuroblastoma cell lines","volume":"39","author":"Valentiner","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1016\/j.mehy.2020.110342_b0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J Peripheral Nervous System"},{"key":"10.1016\/j.mehy.2020.110342_b0165","doi-asserted-by":"crossref","first-page":"242","DOI":"10.47276\/lr.79.3.242","article-title":"The biology of nerve injury in leprosy","volume":"79","author":"Scollard","year":"2008","journal-title":"Lepr Rev"},{"key":"10.1016\/j.mehy.2020.110342_b0170","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4269\/ajtmh.16-0306","article-title":"Guillain-Barr\u00e9 syndrome after zika virus infection in Brazil","volume":"95","author":"do Ros\u00e1rio","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.mehy.2020.110342_b0175","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1086\/655136","article-title":"Increased risk of Guillain-Barr\u00e9 syndrome following recent herpes zoster: a population-based study across Taiwan","volume":"51","author":"Kang","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mehy.2020.110342_b0180","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1212\/01.WNL.0000099171.26943.D0","article-title":"Peripheral nerve disease in SARS: report of a case","volume":"61","author":"Chao","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2020.110342_b0185","first-page":"32","article-title":"Neuromusculoskeletal disorders following SARS: a case series","volume":"55","author":"Stainsby","year":"2011","journal-title":"J Can Chiropr Assoc"},{"key":"10.1016\/j.mehy.2020.110342_b0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-5728(95)00102-8","article-title":"HLA-class II alleles in Guillain-Barr\u00e9 syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection","volume":"62","author":"Rees","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2020.110342_b0195","doi-asserted-by":"crossref","unstructured":"Jin P-P, Sun L-L, Ding B-J, et al., Human Leukocyte Antigen DQB1 (HLA-DQB1) Polymorphisms and the Risk for Guillain-Barr\u00e9 Syndrome: A Systematic Review and Meta-Analysis, PloS one 10 (2015), pp. e0131374-e0131374.","DOI":"10.1371\/journal.pone.0131374"},{"key":"10.1016\/j.mehy.2020.110342_b0200","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/acn3.50884","article-title":"Human leukocyte antigen-DQB1 polymorphisms and haplotype patterns in Guillain-Barr\u00e9 syndrome","volume":"6","author":"Hayat","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.mehy.2020.110342_b0205","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s00415-016-8237-6","article-title":"Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barr\u00e9 syndrome","volume":"263","author":"Schirmer","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.mehy.2020.110342_b0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2015.05.017","volume":"285","author":"Blum","year":"2015","journal-title":"J Neuroimmunol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720328978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720328978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:21:57Z","timestamp":1759692117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720328978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":42,"alternative-id":["S0306987720328978"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110342","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110342"}}